))
HCM and New Pharmacological Agents
Manage episode 407135164 series 3558114
Content provided by Selena Smith and American Heart Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Selena Smith and American Heart Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.
18 episodes
Share
